ORBIMED ADVISORS LLC – BioMarin Pharmaceutical Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$145.57M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.04% | 17.6K shares | 4.72M | $84.77 | 1.71M |
| Q2 2022 | share | Increase | +3.20% | 52.68K shares | 13.86M | $82.87 | 1.69M |
| Q1 2022 | share | Increase | +91.32% | 786.15K shares | 50.92M | $77.1 | 1.64M |
| Q4 2021 | share | Increase | +676.27% | 749.98K shares | 67.48M | $89.08 | 860.88K |
| Q3 2021 | share | Increase | 0.00% | 110.9K shares | 8.57M | $77.29 | 110.9K |
| Q2 2020 | share | Decrease | -100.00% | -540.5K shares | -45.67M | $123.34 | 0 |
| Q1 2020 | share | Increase | +1457.64% | 505.8K shares | 42.73M | $84.5 | 540.5K |
| Q4 2019 | share | Increase | 0.00% | 34.7K shares | 2.93M | $84.55 | 34.7K |
| Q3 2019 | share | Decrease | -100.00% | -75K shares | -6.42M | $67.4 | 0 |
| Q3 2019 | put | Decrease | -100.00% | -75K shares | -6.42M | $67.4 | 0 |
| Q2 2019 | share | Decrease | -1.96% | -1.5K shares | -371K | $85.65 | 75K |
| Q2 2019 | put | Decrease | -70.00% | -175K shares | -15.78M | $85.65 | 75K |
| Q1 2019 | put | Increase | 0.00% | 250K shares | 22.20M | $88.83 | 250K |
| Q1 2019 | share | 0.00% | 0 shares | 281K | $88.83 | 76.5K | |
| Q4 2018 | share | 0.00% | 0 shares | -904K | $85.15 | 76.5K | |
| Q3 2018 | call | Decrease | -100.00% | -70K shares | -6.59M | $96.97 | 0 |
| Q3 2018 | share | 0.00% | 0 shares | 212K | $96.97 | 76.5K | |
| Q2 2018 | call | Increase | 0.00% | 70K shares | 6.59M | $94.2 | 70K |
| Q2 2018 | share | Decrease | -47.42% | -69K shares | -4.59M | $94.2 | 76.5K |
| Q1 2018 | share | Increase | +44.63% | 44.9K shares | 2.82M | $81.07 | 145.5K |
| Q4 2017 | share | Decrease | -86.48% | -643.3K shares | -60.26M | $89.17 | 100.6K |
| Q3 2017 | share | Decrease | -24.29% | -238.7K shares | -20.00M | $93.07 | 743.9K |
| Q2 2017 | share | Decrease | -22.88% | -291.5K shares | -22.6M | $90.82 | 982.6K |
| Q1 2017 | share | 0.00% | 0 shares | 6.29M | $87.78 | 1.27M | |
| Q4 2016 | share | Increase | +10.61% | 122.2K shares | -1.02M | $82.84 | 1.27M |
| Q3 2016 | share | Decrease | -24.14% | -366.6K shares | -11.56M | $92.52 | 1.15M |
| Q2 2016 | share | Increase | +48.41% | 495.3K shares | 33.74M | $77.8 | 1.51M |
| Q1 2016 | share | Increase | +586.71% | 874.2K shares | 68.78M | $82.48 | 1.02M |